search icon
search icon
Flag Arrow Down
Română
Română
Magyar
Magyar
English
English
Français
Français
Deutsch
Deutsch
Italiano
Italiano
Español
Español
Русский
Русский
日本語
日本語
中国人
中国人

Change Language

arrow down
  • Română
    Română
  • Magyar
    Magyar
  • English
    English
  • Français
    Français
  • Deutsch
    Deutsch
  • Italiano
    Italiano
  • Español
    Español
  • Русский
    Русский
  • 日本語
    日本語
  • 中国人
    中国人
Sections
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • EU
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
About Us
Contact
Privacy policy
Terms and conditions
Quickly scroll through news digests and see how they are covered in different publications!
  • News
  • Exclusive
    • INSCOP Surveys
    • Podcast
    • EU
    • Diaspora
    • Republic of Moldova
    • Politics
    • Economy
    • Current Affairs
    • International
    • Sport
    • Health
    • Education
    • IT&C knowledge
    • Arts & Lifestyle
    • Opinions
    • Elections 2025
    • Environment
130 new news items in the last 24 hours
  1. Home
  2. Health

The Novo Nordisk company is stopping the production of human insulin pen-type insulin syringes, affecting people with type 1 diabetes.

Călin Nicolescu
whatsapp
facebook
linkedin
x
copy-link copy-link
16 October 2024, 09:14
main event image
Health
Foto Pixabay
google-preference

Always see our news on Google

People with type 1 diabetes who depend on human insulin made by Novo Nordisk will instead be given glass vials and syringes - said to be inconvenient and harder to use with the same precision. Novo Nordisk has already stopped supply in South Africa, where patients have had to switch to glass vials. Novo Nordisk's decision is linked to its favoring of the marketing of the slimming drugs Ozempic and Wegovy.

Sources

sursa imagine
Mediafax
O companie farmaceutică ar fi oprit producţia de seringi cu insulină pentru a vinde produse de slăbit
sursa imagine
The Guardian EU
Weight-loss drug firm accused of prioritising profits after halting insulin pen production
sursa imagine
Profit.ro
Novo Nordisk, compania producătoare de medicamente folosite pentru pierderea în greutate, acuzată că prioritizează profiturile după oprirea producției de stilouri cu insulină

Latest News

18:40

UE ajunge la un acord pentru amânarea cu doi ani a obligațiilor privind metanul din importurile de gaze, petrol și cărbune

18:38

Health Minister Alexandru Rogobete discusses new measures for hospitals and medicine stocks with NATO

18:31

The Chamber of Tax Consultants warns: ANAF’s new rules for VAT refunds could block investments

18:19

Eurostat shows employment gaps of at least 18 percentage points between men and women in five regions of Romania

18:19

Two ANAF employees from Argeș were detained after allegedly asking for 40,000 lei to conceal tax irregularities

See more news

NEWS ON THE SAME TOPICS

event image
International
Germany will provide €400 million to maintain Sanofi’s insulin production and reduce the risk of shortages in Europe
event image
IT&C knowledge
Novo collaborates with Anthropic to use artificial intelligence in the research and development of new medicines
event image
Current Affairs
FABC, letter to Ilie Bolojan and the head of CNAS: Three oncology medications are missing, and another eight have supply issues.
event image
International
Eight EU countries call for tougher restrictions on nicotine products
event image
Current Affairs
The president of CNAS, Horațiu Moldovan, stated that the disruptions in the supply of medicines, including chemotherapy drugs, are not caused by a lack of funding.
event image
Health
Bucharest’s Neurology Institute postpones procedures due to a shortage of materials
app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview app preview
diabetes insulin new nordisk Wegovy ozempic

Editor’s Recommendations

main event image
INSCOP Surveys
9 hours ago

November 2026: Informat.ro – INSCOP Research BAROMETER, 15th Edition – Chapter X: Temporary Restriction of Access to Online Platforms

main event image
Exclusive
1 hour ago

EXCLUSIVE Ranking of companies in relevant online sources in Romania: Nvidia dominates company visibility. Finance and investments lead the economic agenda

main event image
Opinions
7 hours ago

Andrei Pleșu: What Our Ministers Were and What They Have Become

main event image
Exclusive
8 hours ago

EXCLUSIVE The top domestic political topics trending over the past week / The Lyrica shortage crisis, Marian Neacșu’s new responsibilities, and debates over administrative reform

app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview
app store badge google play badge
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • EU
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
  • About Us
  • Contact
Privacy policy
Cookies Policy
Terms and conditions
Open source licenses
All rights reserved Strategic Media Team SRL

Technology in partnership with

anpc-sal anpc-sol